9th Dimension Biotech
9th Dimension Biotech tree emblem PLANT SCIENCE · HUMAN HEALTH · EST. 2013

Planting the seeds of human health.

Bioengineering new plant varieties for human longevity. Our goal is to turn back the biological clock caused by aging and aging-related diseases. Our premier product, FORZA, just completed a Phase II clinical trial in progressive multiple sclerosis to prove efficacy as an adjuvant to standard therapy.

PARTNER WITH US
I · THE PROTEIN

OSMOTIN

One protein. A platform of possibilities.

For decades, osmotin was known to science and out of reach. 9th Dimension Biotech unlocked it, sourced from ETERNA TAO, our proprietary kiwi variety.

ETERNA TAO A 9TH DIMENSION BIOTECH VARIETY · Actinidia deliciosa
ETERNA TAO kiwi branch with flowers and fruit
Kiwi leaf from ETERNA TAO
II · THE PRODUCT

FORZA

An orally delivered, plant-based bio-encapsulated Osmotin product.

The osmotin protein mimics the human hormone Adiponectin. It is a naturally occurring plant protein amplified in FORZA as a powerful nutritional supplement that activates the therapeutic and anti-aging properties of the proven Calorie Restriction pathway. We grow it in a proprietary kiwi variety and deliver it as whole lyophilized plant material, so the plant itself carries the protein through digestion.

III · THE PROOF

A Phase II trial in progressive multiple sclerosis.

In partnership with the Multiple Sclerosis Foundation of Italy. 9th Dimension was invited to celebrate the successful completion of the clinical trial by the National University of Singapore, School of Medicine International Council at the NIC Conference in Rome, Italy, this October. The trial protocol was peer reviewed and published in PLOS ONE.

PATIENTS50Enrolled
DESIGN12 MO6 months observed, then 6 on treatment
PROTOCOLPLOS ONEPeer-reviewed protocol, 2025
READOUTOCT 2026NIC Conference · Rome, Italy

Osmotin Plant Protein for Progressive Multiple Sclerosis · NCT05937802 · Fondazione Italiana Sclerosi Multipla, IRCCS Ospedale Policlinico San Martino (Genoa) and Sant'Andrea (Rome)

IV · THE PLATFORM

“ONE MECHANISM. MANY DISEASES.”

PROFESSOR DOUGLAS WATT, PH.D. · CLINICAL NEUROSCIENCE ADVISOR

FORZA is shown to affect patient outcomes across multiple conditions, from multiple sclerosis to diabetes, Parkinson's and more. FORZA is the foundation for a pipeline of adjuvant therapies to come.

TESTING ROADMAP
IMULTIPLE SCLEROSISPHASE II COMPLETE
IIPARKINSON'S DISEASENEXT TRIAL
IIITHE PIPELINETHERAPIES TO COME
V · IN THEIR OWN WORDS
“It feels like FORZA™ has changed my life! My hand is so straight and I can use it with very little issues now.”
BIANCA · MULTIPLE SCLEROSIS · AUSTRALIA · MAY 2021
“Not only did my brain function stop its decline, but it began substantially to improve.”
ANN · ALZHEIMER'S DISEASE · USA
“With every dosing regimen I experienced symptomology relief. My spasticity decreased with increasing doses.”
JEFF · SPINAL CORD INJURY · USA
READ ALL REVIEWS

Individual experiences shared with 9th Dimension Biotech. They are not clinical trial results, and individual results vary. These statements have not been evaluated by the Food and Drug Administration. FORZA is not intended to diagnose, treat, cure, or prevent any disease.

Planting the seeds of human health

PARTNER WITH US
VI · CONTACT

BE FIRST TO HEAR

Investors, clinicians and partners can request a briefing ahead of the October presentation. We reply to every note personally.

We use your details only to reply to you.